Literature DB >> 12554088

A novel sialylated and galactofuranose-containing O-linked glycan, Neu5Acalpha2-->3Galpbeta1-->6(Galfbeta1-->4)GlcNAc, is expressed on the sialoglycoprotein of Trypanosoma cruzi Dm28c.

Orlando A Agrellos1, Christopher Jones, Adriane R Todeschini, José O Previato, Lúcia Mendonça-Previato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12554088     DOI： 10.1016/s0166-6851(02)00245-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  7 in total

1.  Golgi UDP-GlcNAc:polypeptide O-α-N-Acetyl-d-glucosaminyltransferase 2 (TcOGNT2) regulates trypomastigote production and function in Trypanosoma cruzi.

Authors:  Carolina M Koeller; Hanke van der Wel; Christa L Feasley; Fernanda Abreu; Juliana Dutra Barbosa da Rocha; Fabrício Montalvão; Patrícia Fampa; Flávia C G Dos Reis; Georgia C Atella; Thaís Souto-Padrón; Christopher M West; Norton Heise
Journal:  Eukaryot Cell       Date:  2014-08-01

Review 2.  Molecular analysis of early host cell infection by Trypanosoma cruzi.

Authors:  Fernando Villalta; M Nia Madison; Yuliya Y Kleshchenko; Pius N Nde; Maria F Lima
Journal:  Front Biosci       Date:  2008-05-01

3.  Sialic acid: a sweet swing between mammalian host and Trypanosoma cruzi.

Authors:  Leonardo Freire-de-Lima; Isadora A Oliveira; Jorge L Neves; Luciana L Penha; Frederico Alisson-Silva; Wagner B Dias; Adriane R Todeschini
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

4.  Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' disease.

Authors:  Michelle Oppenheimer; Ana L Valenciano; Pablo Sobrado
Journal:  Enzyme Res       Date:  2011-05-25

Review 5.  Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi.

Authors:  Lucia Mendonça-Previato; Luciana Penha; Tatiana Cortes Garcez; Christopher Jones; Jose Osvaldo Previato
Journal:  Glycoconj J       Date:  2013-02-21       Impact factor: 2.916

Review 6.  Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines.

Authors:  Sandra Pinzón Martín; Peter H Seeberger; Daniel Varón Silva
Journal:  Front Chem       Date:  2019-10-22       Impact factor: 5.221

Review 7.  The Glycan Structure of T. cruzi mucins Depends on the Host. Insights on the Chameleonic Galactose.

Authors:  María Eugenia Giorgi; Rosa M de Lederkremer
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.